Bill
SB 284
Kansas bill prohibits drug manufacturers from restricting how hospitals and charities distribute discounted medications obtained through the federal 340B pricing program.
SB 284 aims to protect the 340B drug pricing program by prohibiting pharmaceutical manufacturers from interfering with or restricting how covered entities (hospitals, health centers, and charities) distribute discounted drugs obtained through this federal program. The bill seeks to prevent manufacturers from imposing contractual restrictions that limit where or how 340B drugs can be dispensed or distributed.
The 340B program is a federal initiative that requires manufacturers to sell drugs at discounted prices to eligible healthcare entities serving uninsured and low-income patients. Manufacturers have increasingly restricted 340B drug distribution through contractual "restrictions" or price increases, which undermines the program's original intent and can limit patient access to affordable medications. This state-level bill attempts to address manufacturer practices that may conflict with federal program goals.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
